• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

两性霉素B在几种哺乳动物中的比较药代动力学及种间缩放

Comparative pharmacokinetics and interspecies scaling of amphotericin B in several mammalian species.

作者信息

Hutchaleelaha A, Chow H H, Mayersohn M

机构信息

Department of Pharmacy Practice and Science, College of Pharmacy, University of Arizona, Tucson 85721, USA.

出版信息

J Pharm Pharmacol. 1997 Feb;49(2):178-83. doi: 10.1111/j.2042-7158.1997.tb06775.x.

DOI:10.1111/j.2042-7158.1997.tb06775.x
PMID:9055191
Abstract

This study employed several interspecies scaling methods, to evaluate the applicability of extrapolating to man, pharmacokinetic information obtained from animals for amphotericin B, an anti-fungal drug. Pharmacokinetic parameters from four animal species (mouse, rat, monkey and dog) and man were obtained from the literature or from analysis of data reported in the literature. The allometric relationships (obtained from four animal species) as a function of species body weight (W; kg) for systemic clearance per maximum life span potential (CLS/MLP), steady-state volume of distribution (VSS), apparent volume of distribution (V beta) and volume of the central compartment (VC) were: 5691W1.096; 2.46W0.839; 3.08W0.948 and 1.07W0.965, respectively. The allometric relationships for half-life (h) and mean residence time (h) did not scale well with body weight. The prediction of pharmacokinetic parameters in man from the allometric equations do not always agree with those reported in the literature which are based upon a limited number of studies with few human subjects. The plasma concentration-time profiles from these animals were adjusted by normalizing the concentration with dose/W0.948, and re-plotted on different pharmacokinetic time scales. The syndesichrons plot produced an almost superimposable profile of adjusted concentrations as a function of adjusted time among the four species.

摘要

本研究采用了几种种间缩放方法,以评估将从动物获得的抗真菌药物两性霉素B的药代动力学信息外推至人类的适用性。四种动物物种(小鼠、大鼠、猴和狗)以及人类的药代动力学参数是从文献中获取的,或通过对文献报道的数据进行分析得到的。每最大寿命潜力的全身清除率(CLS/MLP)、稳态分布容积(VSS)、表观分布容积(Vβ)和中央室容积(VC)作为物种体重(W;kg)的函数的异速生长关系(从四种动物物种获得)分别为:5691W1.096;2.46W0.839;3.08W0.948和1.07W0.965。半衰期(h)和平均驻留时间(h)的异速生长关系与体重的缩放效果不佳。根据异速生长方程对人类药代动力学参数的预测并不总是与文献中报道的结果一致,文献中的结果基于对少数人类受试者的有限研究。通过用剂量/W0.948对浓度进行归一化来调整这些动物的血浆浓度-时间曲线,并在不同的药代动力学时间尺度上重新绘制。同步图产生了四种物种中调整浓度作为调整时间的函数的几乎可叠加的曲线。

相似文献

1
Comparative pharmacokinetics and interspecies scaling of amphotericin B in several mammalian species.两性霉素B在几种哺乳动物中的比较药代动力学及种间缩放
J Pharm Pharmacol. 1997 Feb;49(2):178-83. doi: 10.1111/j.2042-7158.1997.tb06775.x.
2
Elucidation of human amphotericin B pharmacokinetics: identification of a new potential factor affecting interspecies pharmacokinetic scaling.人两性霉素B药代动力学的阐明:确定影响种间药代动力学标度的一个新的潜在因素。
Pharm Res. 1998 Oct;15(10):1630-6. doi: 10.1023/a:1011923704731.
3
Comparative pharmacokinetics and interspecies scaling of 3'-azido-3'-deoxythymidine (AZT) in several mammalian species.3'-叠氮-3'-脱氧胸苷(AZT)在几种哺乳动物物种中的比较药代动力学及种间缩放
J Pharmacobiodyn. 1990 Mar;13(3):206-11. doi: 10.1248/bpb1978.13.206.
4
Interspecies pharmacokinetic scaling of oltipraz in mice, rats, rabbits and dogs, and prediction of human pharmacokinetics.奥替普拉在小鼠、大鼠、家兔和犬体内的种间药代动力学尺度缩放及人体药代动力学预测。
Biopharm Drug Dispos. 2005 Apr;26(3):99-115. doi: 10.1002/bdd.437.
5
Interspecies scaling: predicting volumes, mean residence time and elimination half-life. Some suggestions.种间缩放:预测体积、平均驻留时间和消除半衰期。一些建议。
J Pharm Pharmacol. 1998 May;50(5):493-9. doi: 10.1111/j.2042-7158.1998.tb06190.x.
6
Pharmacokinetic and toxicity scaling of the antitumor agents amsacrine and CI-921, a new analogue, in mice, rats, rabbits, dogs, and humans.抗肿瘤药物安吖啶和新类似物CI-921在小鼠、大鼠、兔子、狗和人类体内的药代动力学及毒性换算
Cancer Res. 1990 May 1;50(9):2692-7.
7
Interspecies allometric analysis of the comparative pharmacokinetics of 44 drugs across veterinary and laboratory animal species.44种药物在兽医和实验动物物种间比较药代动力学的种间异速生长分析。
J Vet Pharmacol Ther. 1997 Dec;20(6):453-63. doi: 10.1046/j.1365-2885.1997.00095.x.
8
Inter-species extrapolation of pharmacokinetic data of three prostacyclin-mimetics.三种前列环素类似物药代动力学数据的种间外推
Prostaglandins. 1994 Nov;48(5):297-312. doi: 10.1016/0090-6980(94)90030-2.
9
Interspecies pharmacokinetic scaling of DA-8159, a new erectogenic, in mice, rats, rabbits and dogs, and prediction of human pharmacokinetics.新型勃起功能障碍治疗药物DA-8159在小鼠、大鼠、兔子和狗体内的种间药代动力学缩放以及人体药代动力学预测。
Biopharm Drug Dispos. 2005 Oct;26(7):269-77. doi: 10.1002/bdd.455.
10
Prediction of clearance, volume of distribution and half-life by allometric scaling and by use of plasma concentrations predicted from pharmacokinetic constants: a comparative study.通过异速生长比例缩放法以及利用从药代动力学常数预测的血浆浓度来预测清除率、分布容积和半衰期:一项对比研究。
J Pharm Pharmacol. 1999 Aug;51(8):905-10. doi: 10.1211/0022357991773320.

引用本文的文献

1
A Simple Method for the Prediction of Human Concentration-Time Profiles and Pharmacokinetics of Antibody-Drug Conjugates (ADC) from Rats or Monkeys.一种从大鼠或猴子预测抗体药物偶联物(ADC)人体浓度-时间曲线和药代动力学的简单方法。
Antibodies (Basel). 2022 Jun 14;11(2):42. doi: 10.3390/antib11020042.
2
Interspecies scaling and prediction of human clearance: comparison of small- and macro-molecule drugs.种间尺度转换与人体清除率预测:小分子药物与大分子药物的比较
Xenobiotica. 2011 Nov;41(11):972-87. doi: 10.3109/00498254.2011.598582. Epub 2011 Sep 5.
3
Physiologically based pharmacokinetic model of amphotericin B disposition in rats following administration of deoxycholate formulation (Fungizone®): pooled analysis of published data.
去氧胆酸盐制剂(两性霉素 B 脂质体)给药后大鼠体内两性霉素 B 处置的基于生理学的药代动力学模型:已发表数据的汇总分析。
AAPS J. 2011 Jun;13(2):255-64. doi: 10.1208/s12248-011-9267-8. Epub 2011 Mar 23.
4
Interspecies scaling for the prediction of drug clearance in children: application of maximum lifespan potential and an empirical correction factor.种间比例预测儿童药物清除率:最大寿命潜能和经验校正因子的应用。
Clin Pharmacokinet. 2010 Jul;49(7):479-92. doi: 10.2165/11531830-000000000-00000.
5
A novel strategy for physiologically based predictions of human pharmacokinetics.一种基于生理学的人体药代动力学预测新策略。
Clin Pharmacokinet. 2006;45(5):511-42. doi: 10.2165/00003088-200645050-00006.
6
Drug disposition viewed in terms of the fractal volume of distribution.从分布分形体积的角度看待药物处置。
Pharm Res. 2002 May;19(5):696-703. doi: 10.1023/a:1015378701592.
7
Fractal volume of drug distribution: it scales proportionally to body mass.药物分布的分形体积:它与体重成比例缩放。
Pharm Res. 2001 Jul;18(7):1056-60. doi: 10.1023/a:1010965001162.
8
Pharmacokinetics-pharmacodynamics of a sordarin derivative (GM 237354) in a murine model of lethal candidiasis.一种梭链孢酸衍生物(GM 237354)在致死性念珠菌病小鼠模型中的药代动力学-药效学
Antimicrob Agents Chemother. 2000 Sep;44(9):2333-40. doi: 10.1128/AAC.44.9.2333-2340.2000.
9
Allometric pharmacokinetic scaling: towards the prediction of human oral pharmacokinetics.异速生长药代动力学标度:迈向人类口服药代动力学的预测
Pharm Res. 2000 Apr;17(4):410-8. doi: 10.1023/a:1007520818956.
10
Prediction of hepatic metabolic clearance based on interspecies allometric scaling techniques and in vitro-in vivo correlations.基于种间异速生长比例技术和体外-体内相关性预测肝脏代谢清除率。
Clin Pharmacokinet. 1999 Mar;36(3):211-31. doi: 10.2165/00003088-199936030-00003.